1. Home
  2. TRNO vs GRFS Comparison

TRNO vs GRFS Comparison

Compare TRNO & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terreno Realty Corporation

TRNO

Terreno Realty Corporation

HOLD

Current Price

$62.48

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.23

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRNO
GRFS
Founded
2009
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.2B
IPO Year
2010
2006

Fundamental Metrics

Financial Performance
Metric
TRNO
GRFS
Price
$62.48
$9.23
Analyst Decision
Buy
Hold
Analyst Count
12
2
Target Price
$65.58
$10.15
AVG Volume (30 Days)
685.8K
459.5K
Earning Date
02-05-2026
07-28-2022
Dividend Yield
3.33%
1.54%
EPS Growth
75.67
N/A
EPS
3.15
0.64
Revenue
$442,611,000.00
$8,821,017,248.00
Revenue This Year
$23.60
$5.36
Revenue Next Year
$7.96
$5.15
P/E Ratio
$19.87
$17.85
Revenue Growth
21.13
7.31
52 Week Low
$48.18
$6.19
52 Week High
$69.20
$11.14

Technical Indicators

Market Signals
Indicator
TRNO
GRFS
Relative Strength Index (RSI) 60.99 53.93
Support Level $58.77 $8.63
Resistance Level $63.17 $9.40
Average True Range (ATR) 1.15 0.23
MACD 0.34 -0.02
Stochastic Oscillator 82.57 65.43

Price Performance

Historical Comparison
TRNO
GRFS

About TRNO Terreno Realty Corporation

Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: